| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.006 | 1 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.0024 | 1 |